Animal Blood Plasma and Derivatives Market, Global Outlook and Forecast 2022-2028

February 2022 | 61 pages | ID: AD058C7423F0EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Animal Blood Plasma and Derivatives in Global, including the following market information:

Global Animal Blood Plasma and Derivatives Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Animal Blood Plasma and Derivatives market was valued at 1027.2 million in 2021 and is projected to reach US$ 1379.9 million by 2028, at a CAGR of 4.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Immunoglobulin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Animal Blood Plasma and Derivatives include Proliant Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Kraeber & Co GmbH, LAMPIRE Biological Laboratories, Inc., Lake Immunogenics, Inc., Rocky Mountain Biologicals Inc., ANZCO Foods Ltd. and Auckland BioSciences Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Animal Blood Plasma and Derivatives companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Animal Blood Plasma and Derivatives Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Animal Blood Plasma and Derivatives Market Segment Percentages, by Type, 2021 (%)

• Immunoglobulin
• Fibrinogen
• Serum Albumin
• Fetal Bovine Serum
• Thrombin
• New Born Calf Serum

Global Animal Blood Plasma and Derivatives Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Animal Blood Plasma and Derivatives Market Segment Percentages, by Application, 2021 (%)

• Food & Beverages
• Pharmaceuticals
• Cosmetics
• Feed
• Others

Global Animal Blood Plasma and Derivatives Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Animal Blood Plasma and Derivatives Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Animal Blood Plasma and Derivatives revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Animal Blood Plasma and Derivatives revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Proliant Inc.
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Kraeber & Co GmbH
• LAMPIRE Biological Laboratories, Inc.
• Lake Immunogenics, Inc.
• Rocky Mountain Biologicals Inc.
• ANZCO Foods Ltd.
• Auckland BioSciences Ltd.
• Bovogen Biologicals Pty Ltd.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Animal Blood Plasma and Derivatives Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Animal Blood Plasma and Derivatives Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANIMAL BLOOD PLASMA AND DERIVATIVES OVERALL MARKET SIZE

2.1 Global Animal Blood Plasma and Derivatives Market Size: 2021 VS 2028
2.2 Global Animal Blood Plasma and Derivatives Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Animal Blood Plasma and Derivatives Players in Global Market
3.2 Top Global Animal Blood Plasma and Derivatives Companies Ranked by Revenue
3.3 Global Animal Blood Plasma and Derivatives Revenue by Companies
3.4 Top 3 and Top 5 Animal Blood Plasma and Derivatives Companies in Global Market, by Revenue in 2021
3.5 Global Companies Animal Blood Plasma and Derivatives Product Type
3.6 Tier 1, Tier 2 and Tier 3 Animal Blood Plasma and Derivatives Players in Global Market
  3.6.1 List of Global Tier 1 Animal Blood Plasma and Derivatives Companies
  3.6.2 List of Global Tier 2 and Tier 3 Animal Blood Plasma and Derivatives Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Animal Blood Plasma and Derivatives Market Size Markets, 2021 & 2028
  4.1.2 Immunoglobulin
  4.1.3 Fibrinogen
  4.1.4 Serum Albumin
  4.1.5 Fetal Bovine Serum
  4.1.6 Thrombin
  4.1.7 New Born Calf Serum
4.2 By Type - Global Animal Blood Plasma and Derivatives Revenue & Forecasts
  4.2.1 By Type - Global Animal Blood Plasma and Derivatives Revenue, 2017-2022
  4.2.2 By Type - Global Animal Blood Plasma and Derivatives Revenue, 2023-2028
  4.2.3 By Type - Global Animal Blood Plasma and Derivatives Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Animal Blood Plasma and Derivatives Market Size, 2021 & 2028
  5.1.2 Food & Beverages
  5.1.3 Pharmaceuticals
  5.1.4 Cosmetics
  5.1.5 Feed
  5.1.6 Others
5.2 By Application - Global Animal Blood Plasma and Derivatives Revenue & Forecasts
  5.2.1 By Application - Global Animal Blood Plasma and Derivatives Revenue, 2017-2022
  5.2.2 By Application - Global Animal Blood Plasma and Derivatives Revenue, 2023-2028
  5.2.3 By Application - Global Animal Blood Plasma and Derivatives Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Animal Blood Plasma and Derivatives Market Size, 2021 & 2028
6.2 By Region - Global Animal Blood Plasma and Derivatives Revenue & Forecasts
  6.2.1 By Region - Global Animal Blood Plasma and Derivatives Revenue, 2017-2022
  6.2.2 By Region - Global Animal Blood Plasma and Derivatives Revenue, 2023-2028
  6.2.3 By Region - Global Animal Blood Plasma and Derivatives Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Animal Blood Plasma and Derivatives Revenue, 2017-2028
  6.3.2 US Animal Blood Plasma and Derivatives Market Size, 2017-2028
  6.3.3 Canada Animal Blood Plasma and Derivatives Market Size, 2017-2028
  6.3.4 Mexico Animal Blood Plasma and Derivatives Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Animal Blood Plasma and Derivatives Revenue, 2017-2028
  6.4.2 Germany Animal Blood Plasma and Derivatives Market Size, 2017-2028
  6.4.3 France Animal Blood Plasma and Derivatives Market Size, 2017-2028
  6.4.4 U.K. Animal Blood Plasma and Derivatives Market Size, 2017-2028
  6.4.5 Italy Animal Blood Plasma and Derivatives Market Size, 2017-2028
  6.4.6 Russia Animal Blood Plasma and Derivatives Market Size, 2017-2028
  6.4.7 Nordic Countries Animal Blood Plasma and Derivatives Market Size, 2017-2028
  6.4.8 Benelux Animal Blood Plasma and Derivatives Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Animal Blood Plasma and Derivatives Revenue, 2017-2028
  6.5.2 China Animal Blood Plasma and Derivatives Market Size, 2017-2028
  6.5.3 Japan Animal Blood Plasma and Derivatives Market Size, 2017-2028
  6.5.4 South Korea Animal Blood Plasma and Derivatives Market Size, 2017-2028
  6.5.5 Southeast Asia Animal Blood Plasma and Derivatives Market Size, 2017-2028
  6.5.6 India Animal Blood Plasma and Derivatives Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Animal Blood Plasma and Derivatives Revenue, 2017-2028
  6.6.2 Brazil Animal Blood Plasma and Derivatives Market Size, 2017-2028
  6.6.3 Argentina Animal Blood Plasma and Derivatives Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Animal Blood Plasma and Derivatives Revenue, 2017-2028
  6.7.2 Turkey Animal Blood Plasma and Derivatives Market Size, 2017-2028
  6.7.3 Israel Animal Blood Plasma and Derivatives Market Size, 2017-2028
  6.7.4 Saudi Arabia Animal Blood Plasma and Derivatives Market Size, 2017-2028
  6.7.5 UAE Animal Blood Plasma and Derivatives Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Proliant Inc.
  7.1.1 Proliant Inc. Corporate Summary
  7.1.2 Proliant Inc. Business Overview
  7.1.3 Proliant Inc. Animal Blood Plasma and Derivatives Major Product Offerings
  7.1.4 Proliant Inc. Animal Blood Plasma and Derivatives Revenue in Global Market (2017-2022)
  7.1.5 Proliant Inc. Key News
7.2 Thermo Fisher Scientific, Inc.
  7.2.1 Thermo Fisher Scientific, Inc. Corporate Summary
  7.2.2 Thermo Fisher Scientific, Inc. Business Overview
  7.2.3 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Major Product Offerings
  7.2.4 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Revenue in Global Market (2017-2022)
  7.2.5 Thermo Fisher Scientific, Inc. Key News
7.3 Merck KGaA
  7.3.1 Merck KGaA Corporate Summary
  7.3.2 Merck KGaA Business Overview
  7.3.3 Merck KGaA Animal Blood Plasma and Derivatives Major Product Offerings
  7.3.4 Merck KGaA Animal Blood Plasma and Derivatives Revenue in Global Market (2017-2022)
  7.3.5 Merck KGaA Key News
7.4 Kraeber & Co GmbH
  7.4.1 Kraeber & Co GmbH Corporate Summary
  7.4.2 Kraeber & Co GmbH Business Overview
  7.4.3 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Major Product Offerings
  7.4.4 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Revenue in Global Market (2017-2022)
  7.4.5 Kraeber & Co GmbH Key News
7.5 LAMPIRE Biological Laboratories, Inc.
  7.5.1 LAMPIRE Biological Laboratories, Inc. Corporate Summary
  7.5.2 LAMPIRE Biological Laboratories, Inc. Business Overview
  7.5.3 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Major Product Offerings
  7.5.4 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Revenue in Global Market (2017-2022)
  7.5.5 LAMPIRE Biological Laboratories, Inc. Key News
7.6 Lake Immunogenics, Inc.
  7.6.1 Lake Immunogenics, Inc. Corporate Summary
  7.6.2 Lake Immunogenics, Inc. Business Overview
  7.6.3 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Major Product Offerings
  7.6.4 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Revenue in Global Market (2017-2022)
  7.6.5 Lake Immunogenics, Inc. Key News
7.7 Rocky Mountain Biologicals Inc.
  7.7.1 Rocky Mountain Biologicals Inc. Corporate Summary
  7.7.2 Rocky Mountain Biologicals Inc. Business Overview
  7.7.3 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Major Product Offerings
  7.7.4 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Revenue in Global Market (2017-2022)
  7.7.5 Rocky Mountain Biologicals Inc. Key News
7.8 ANZCO Foods Ltd.
  7.8.1 ANZCO Foods Ltd. Corporate Summary
  7.8.2 ANZCO Foods Ltd. Business Overview
  7.8.3 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Major Product Offerings
  7.8.4 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Revenue in Global Market (2017-2022)
  7.8.5 ANZCO Foods Ltd. Key News
7.9 Auckland BioSciences Ltd.
  7.9.1 Auckland BioSciences Ltd. Corporate Summary
  7.9.2 Auckland BioSciences Ltd. Business Overview
  7.9.3 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Major Product Offerings
  7.9.4 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Revenue in Global Market (2017-2022)
  7.9.5 Auckland BioSciences Ltd. Key News
7.10 Bovogen Biologicals Pty Ltd.
  7.10.1 Bovogen Biologicals Pty Ltd. Corporate Summary
  7.10.2 Bovogen Biologicals Pty Ltd. Business Overview
  7.10.3 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Major Product Offerings
  7.10.4 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Revenue in Global Market (2017-2022)
  7.10.5 Bovogen Biologicals Pty Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Animal Blood Plasma and Derivatives Market Opportunities & Trends in Global Market
Table 2. Animal Blood Plasma and Derivatives Market Drivers in Global Market
Table 3. Animal Blood Plasma and Derivatives Market Restraints in Global Market
Table 4. Key Players of Animal Blood Plasma and Derivatives in Global Market
Table 5. Top Animal Blood Plasma and Derivatives Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Animal Blood Plasma and Derivatives Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Animal Blood Plasma and Derivatives Revenue Share by Companies, 2017-2022
Table 8. Global Companies Animal Blood Plasma and Derivatives Product Type
Table 9. List of Global Tier 1 Animal Blood Plasma and Derivatives Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Animal Blood Plasma and Derivatives Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Animal Blood Plasma and Derivatives Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Animal Blood Plasma and Derivatives Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Animal Blood Plasma and Derivatives Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Animal Blood Plasma and Derivatives Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Animal Blood Plasma and Derivatives Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Animal Blood Plasma and Derivatives Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2023-2028
Table 30. Proliant Inc. Corporate Summary
Table 31. Proliant Inc. Animal Blood Plasma and Derivatives Product Offerings
Table 32. Proliant Inc. Animal Blood Plasma and Derivatives Revenue (US$, Mn), (2017-2022)
Table 33. Thermo Fisher Scientific, Inc. Corporate Summary
Table 34. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Product Offerings
Table 35. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Revenue (US$, Mn), (2017-2022)
Table 36. Merck KGaA Corporate Summary
Table 37. Merck KGaA Animal Blood Plasma and Derivatives Product Offerings
Table 38. Merck KGaA Animal Blood Plasma and Derivatives Revenue (US$, Mn), (2017-2022)
Table 39. Kraeber & Co GmbH Corporate Summary
Table 40. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Product Offerings
Table 41. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Revenue (US$, Mn), (2017-2022)
Table 42. LAMPIRE Biological Laboratories, Inc. Corporate Summary
Table 43. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Product Offerings
Table 44. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Revenue (US$, Mn), (2017-2022)
Table 45. Lake Immunogenics, Inc. Corporate Summary
Table 46. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Product Offerings
Table 47. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Revenue (US$, Mn), (2017-2022)
Table 48. Rocky Mountain Biologicals Inc. Corporate Summary
Table 49. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Product Offerings
Table 50. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Revenue (US$, Mn), (2017-2022)
Table 51. ANZCO Foods Ltd. Corporate Summary
Table 52. ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Product Offerings
Table 53. ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Revenue (US$, Mn), (2017-2022)
Table 54. Auckland BioSciences Ltd. Corporate Summary
Table 55. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Product Offerings
Table 56. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Revenue (US$, Mn), (2017-2022)
Table 57. Bovogen Biologicals Pty Ltd. Corporate Summary
Table 58. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Product Offerings
Table 59. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Animal Blood Plasma and Derivatives Segment by Type in 2021
Figure 2. Animal Blood Plasma and Derivatives Segment by Application in 2021
Figure 3. Global Animal Blood Plasma and Derivatives Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Animal Blood Plasma and Derivatives Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Animal Blood Plasma and Derivatives Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Animal Blood Plasma and Derivatives Revenue in 2021
Figure 8. By Type - Global Animal Blood Plasma and Derivatives Revenue Market Share, 2017-2028
Figure 9. By Application - Global Animal Blood Plasma and Derivatives Revenue Market Share, 2017-2028
Figure 10. By Region - Global Animal Blood Plasma and Derivatives Revenue Market Share, 2017-2028
Figure 11. By Country - North America Animal Blood Plasma and Derivatives Revenue Market Share, 2017-2028
Figure 12. US Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Animal Blood Plasma and Derivatives Revenue Market Share, 2017-2028
Figure 16. Germany Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 17. France Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Animal Blood Plasma and Derivatives Revenue Market Share, 2017-2028
Figure 24. China Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 28. India Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Animal Blood Plasma and Derivatives Revenue Market Share, 2017-2028
Figure 30. Brazil Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Animal Blood Plasma and Derivatives Revenue Market Share, 2017-2028
Figure 33. Turkey Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2017-2028
Figure 37. Proliant Inc. Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck KGaA Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)